Harvard Apparatus Regenerative Technology Investor Relations Material
Latest events
Q3 2023
Harvard Apparatus Regenerative Technology
Q1 2025
13 May, 2025
Q4 2024
30 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harvard Apparatus Regenerative Technology Inc
Access all reports
Harvard Apparatus Regenerative Technology Inc is a U.S.-based biotechnology company developing regenerative medicine solutions. The company focuses on bioengineered implants for airway reconstruction using scaffold and cell technologies. Its research is aimed at treating life-threatening conditions such as tracheal damage and lung diseases. The company is headquartered in Holliston, Massachusetts, and its shares are listed on the OTCQB.
)
)
)